View Document Preview and Link Open Document File Size: 89,52 KB Share Result on Facebook
City Milan / / Company IgG / / Country United Kingdom / / / Facility Medical University of Bialystok / / / IndustryTerm food intolerance / treatment of IgE-mediated diseases / / MedicalCondition loss of consciousness / several inflammatory cell types / progressive dyspnea / frequent / sudden asthma / allergic asthma / well-controlled asthma / disease / death-threatening asthma / airway eosinophilia / fast progressive paroxysmal dyspnea / clinical asthma / Abstract Asthma / heterogeneous disease / nutrient deficiency / allergy / II brittle asthma / inflammatory mediators / Ninan T. Brittle asthma / acute asthma / IgE-mediated diseases / Discussion Asthma / Clin Exp Allergy / atopy / relative immunoglobulin deficiency / tachycardia / inflammatory cascade / brittle allergic asthma / severe persistent allergic asthma / deficiency / inflammation / severe asthma / Brittle asthma / I brittle asthma / asthma / acute and chronic symptoms / / Organization Congress / Department of Allergology and Internal Medicine / Medical University of Bialystok / Anna Bodzenta-Lukaszyk Department of Allergology and Internal Medicine / / Person Anna Bodzenta-Lukaszyk / Roman Skiepko / Arch Allergy / Wojciech Budny / / / Position hypoxic driver / Head / / SocialTag 
Case report Omalizumab treatment in brittle asthma